FDA monthly preview: Key September decisions to watch
MDSpire News
August 28, 2026
You now have access to the trusted editorial news and specialty content you've known from the Conexiant news site—all within the MDSpire experience.
Learn more

Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Affiliations:
Specialties:
Areas of Expertise:
4 Topic Commentaries
FDA monthly preview: Key September decisions to watch
Robert M. Califf, M.D.
Cardiology; regulatory science
•U.S. Food and Drug Administration
Namandjé N. Bumpus, Ph.D.
Pharmacology; regulatory science
•U.S. Food and Drug Administration
Linda Ann Sherman, M.D., M.P.A.
Advisory committee oversight; regulatory affairs
•U.S. Food and Drug Administration
Peter Marks, M.D., Ph.D.
Biologics and vaccines regulation
•U.S. Food and Drug Administration
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.